Latest news with #RoomaSinha
India Today
4 days ago
- Health
- India Today
How robotic surgery is transforming women's health in India
As India observes Women's Health Month, India Today spoke with leading gynaecologists and surgeons behind a landmark multi-institutional study titled 'Trends in Gynecological Robotic Surgery in India: A Real-World Scenario', which is shedding light on how robotic-assisted surgery (RAS) is transforming gynaecological care nationwide. Conducted across five premier tertiary hospitals—Apollo Health City (Hyderabad), PGIMER (Chandigarh), Manipal Hospital (Bangalore), Narayana Hrudayalaya (Bangalore), and Tata Memorial Hospital (Mumbai)—the study showcases how RAS is driving better outcomes for women undergoing surgery for both benign and malignant by data spanning over a decade, the study reflects how innovation in surgical technology is not just enhancing recovery but redefining access and quality in women's healthcare across to the study, more than 70% of all robotic gynaecological surgeries were performed in just the last five years, indicating rapid adoption and growing trust in the technology. This reflects a broader shift in surgical practice, where precision, minimal invasiveness, and faster recovery are becoming central priorities, especially for women who often juggle health with multiple PRECISION FOR COMPLEX GYNAECOLOGICAL CONDITIONS "Dr Rooma Sinha, Honorary Professor and Chief Gynaecologist at Apollo Health City and one of the lead authors of the study, underlines the key value of robotic-assisted surgery: precision. 'Robotic-assisted surgery is increasingly being used to manage benign gynaecological conditions such as fibroids and endometriosis, offering enhanced outcomes across a wide range of cases,' she said. This precision is particularly important in surgeries involving fertility preservation, such as myomectomy—the removal of fibroids while keeping the uterus RECOVERY, LESS BLOOD LOSS, FEWER COMPLICATIONSadvertisementAcross hospitals, the data echoed similar global findings: robotic-assisted procedures resulted in reduced blood loss, shorter hospital stays, and quicker recoveries. These improvements are especially valuable in the Indian healthcare context, where many patients travel long distances for treatment. 'We were able to keep blood loss low and recovery times short—even for large fibroids or complex cases,' said Dr Sinha, who also serves as the Founder-President of the Association of Gynaecological Robotic RESULTS REGARDLESS OF BODY TYPEThe study also found that BMI (Body Mass Index) had no significant impact on surgical outcomes, meaning that RAS can be equally effective across a wide range of body types. Additionally, improved surgical workflows—like shorter docking times as teams gained experience—also contributed to more efficient and safe CONDITIONS TREATED USING ROBOTIC SURGERYAmong the most common conditions treated using RAS wereFibroids (Myomas)EndometriosisAdenomyosisVault prolapseOvarian cystsThese often require intricate dissection and suturing, making robotic assistance especially beneficial. 'Advanced robotic platforms like da Vinci give us better visualisation and control, which makes a real difference in such complex surgeries,' explained Dr Subhas C. Saha, Professor at TOWARDS ACCESSIBLE AND AFFORDABLE RASDespite the benefits, cost and insurance coverage remain major hurdles. However, surgeons are working on refining procedures to lower costs, such as using fewer robotic arms and adopting multifunctional tools. 'There is a strong case for insurers to expand coverage,' Dr Saha added. 'More streamlined reimbursement policies can help ensure that advanced care becomes accessible to a broader population.'advertisementAs robotic surgery continues to evolve and become more mainstream, it is poised to play a pivotal role in the future of women's healthcare in India. Its benefits—faster recovery, fewer complications, and precision—align with the needs of today's patients. With improved access and affordability, robotic-assisted gynaecological surgery could soon become the standard of care, delivering better outcomes for women across the country.
Hans India
5 days ago
- Health
- Hans India
Robotic-assisted surgery steadily transforming gynaecological care: Study
Bengaluru: A study released to coincide with Women's Health Month, is shedding light on how robotic-assisted surgery (RAS) is steadily transforming gynaecological care across the country. May month is observed as Women's Health Month worldwide, to focus on raising awareness about women's health issues and encouraging women to prioritise their physical, mental, and emotional well-being. 'Women's Health Month is a time to reflect on how surgical technology innovations like the da Vinci robotic technology are enhancing healthcare outcomes for women,' said Dr Rooma Sinha, Honorary Professor and Chief Gynaecologist at Apollo Health City, Hyderabad, one of the surgeons who oversaw the study. The multi-institutional study, 'Trends in Gynaecological Robotic Surgery in India: A Real-World Scenario', was conducted across five tertiary care hospitals -- Apollo Health City (Hyderabad), PGIMER (Chandigarh), Manipal Hospital (Bengaluru), Narayana Health (Bengaluru), and Tata Memorial Hospital (Mumbai). It analysed the data of surgeries performed using the da Vinci technology over a decade. The study documents a significant rise in the use of robotic surgery for both benign and malignant conditions and is significant for its implications on access, recovery, and surgical outcomes for women. 'Robotic-assisted surgery is increasingly being used to manage benign gynaecological conditions such as fibroids and endometriosis, offering enhanced precision and improved outcomes across a wide range of cases,' said Dr Sinha, who is also the Founder-President of Association of Gynecological Robotic Surgeons. According to her, over 70 per cent of robotic gynaecological procedures took place in the final five years, indicating a strong upward trajectory. 'We have seen that with robotic procedures, women often spend less time in the hospital and experience fewer complications related to blood loss,' said Dr Vanita Jain, Head of Obstetrics and Gynaecology at PGIMER, Chandigarh, who was also part of the study. She noted that it is not just about using new technology. 'It is about making recovery more manageable, especially for women who are balancing responsibilities at home and work,' added Dr Jain. The study found that fibroids were the most common benign indication for robotic surgery, followed by endometriosis, adenomyosis, vault prolapse, and ovarian cysts. These conditions, said the doctors, often require careful dissection and suturing, particularly when fertility preservation is important. 'Myomectomy, or the removal of fibroids while preserving the uterus, especially calls for such precision,' explained Dr Subhas C Saha, Professor, Department of Obstetrics and Gynaecology, PGIMER, Chandigarh, another key facilitator of the study. 'Advanced robotic systems like the da Vinci platform offer us better visualisation and manoeuvrability, which can make a real difference in these challenging cases,' he added. While more public and private insurers are beginning to include robotic-assisted surgery (RAS) in their coverage, the study highlights that there is still room to improve affordability and access. To optimise value and accessibility, surgeons are refining techniques -- using fewer robotic arms and incorporating multifunctional instruments -- to reduce costs while still delivering high-quality care and better patient outcomes. 'Given the clear benefits demonstrated in studies like this, there is a strong case for insurance payers to further expand coverage for robotic-assisted surgery. Broader, streamlined reimbursement support can help ensure more women across India have access to advanced surgical options,' Dr Saha added.
&w=3840&q=100)
Business Standard
6 days ago
- Health
- Business Standard
Robotic-assisted surgery steadily transforming gynaecological care: study
A study released to coincide with Women's Health Month, is shedding light on how robotic-assisted surgery (RAS) is steadily transforming gynaecological care across the country. May month is observed as Women's Health Month worldwide, to focus on raising awareness about women's health issues and encouraging women to prioritise their physical, mental, and emotional well-being. "Women's Health Month is a time to reflect on how surgical technology innovations like the da Vinci robotic technology are enhancing healthcare outcomes for women," said Dr Rooma Sinha, Honorary Professor and Chief Gynaecologist at Apollo Health City, Hyderabad, one of the surgeons who oversaw the study. The multi-institutional study, 'Trends in Gynaecological Robotic Surgery in India: A Real-World Scenario', was conducted across five tertiary care hospitals -- Apollo Health City (Hyderabad), PGIMER (Chandigarh), Manipal Hospital (Bengaluru), Narayana Health (Bengaluru), and Tata Memorial Hospital (Mumbai). It analysed the data of surgeries performed using the da Vinci technology over a decade. The study documents a significant rise in the use of robotic surgery for both benign and malignant conditions and is significant for its implications on access, recovery, and surgical outcomes for women. "Robotic-assisted surgery is increasingly being used to manage benign gynaecological conditions such as fibroids and endometriosis, offering enhanced precision and improved outcomes across a wide range of cases," said Dr Sinha, who is also the Founder-President of Association of Gynecological Robotic Surgeons. According to her, over 70 per cent of robotic gynaecological procedures took place in the final five years, indicating a strong upward trajectory. "We have seen that with robotic procedures, women often spend less time in the hospital and experience fewer complications related to blood loss," said Dr Vanita Jain, Head of Obstetrics and Gynaecology at PGIMER, Chandigarh, who was also part of the study. She noted that it is not just about using new technology. "It is about making recovery more manageable, especially for women who are balancing responsibilities at home and work," added Dr Jain. The study found that fibroids were the most common benign indication for robotic surgery, followed by endometriosis, adenomyosis, vault prolapse, and ovarian cysts. These conditions, said the doctors, often require careful dissection and suturing, particularly when fertility preservation is important. "Myomectomy, or the removal of fibroids while preserving the uterus, especially calls for such precision," explained Dr Subhas C Saha, Professor, Department of Obstetrics and Gynaecology, PGIMER, Chandigarh, another key facilitator of the study. "Advanced robotic systems like the da Vinci platform offer us better visualisation and manoeuvrability, which can make a real difference in these challenging cases," he added. While more public and private insurers are beginning to include robotic-assisted surgery (RAS) in their coverage, the study highlights that there is still room to improve affordability and access. To optimise value and accessibility, surgeons are refining techniques -- using fewer robotic arms and incorporating multifunctional instruments -- to reduce costs while still delivering high-quality care and better patient outcomes. "Given the clear benefits demonstrated in studies like this, there is a strong case for insurance payers to further expand coverage for robotic-assisted surgery. Broader, streamlined reimbursement support can help ensure more women across India have access to advanced surgical options," Dr Saha added. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
